Understanding the Pros and Cons of ICL Surgery
Discover the pros and cons of ICL surgery for lasting vision correction.
The first iStent InfiniteTM surgery in Australasia was performed at Auckland Eye in July 2022 as part of a clinical research study being sponsored by GLAUKOS Corporation and led in New Zealand by Dr Dean Corbett.
The iStent InfiniteTM is an investigational device designed to reduce elevated intraocular pressure in patients with open-angle glaucoma.
If you have any questions, please feel free to contact our clinical research department at research@aucklandeye.co.nz.

Discover the pros and cons of ICL surgery for lasting vision correction.

Temporary website email delays experienced Wednesday 29th April 2026.

Using GLP-1 medications for diabetes or weight loss? Learn how they may affect your eyes and when to seek advice.